A twice-daily tablet regularly used by the NHS could slow or even reverse certain forms of incurable dementia, a study has claimed. Nilotinib, a blood cancer medicine, was previously shown to ...

See Contraindications. QT prolongation with concomitant dofetilide, quinidine, pimozide, cisapride, methadone, disopyramide, dronedarone, ranolazine. Concomitant ...

Nilotinib (Tasigna®) is a highly potent and selective inhibitor of breakpoint cluster region (BCR)–V-abl Abelson murine leukemia viral oncogene homolog 1 (ABL1), which was rationally designed ...

Now a study from the GIMEMA CML Working Party has shown that nilotinib is safe and effective in patients with early-stage chronic-phase Ph+ CML. The results of this study support the role for this ...

The BCR/ABL1 inhibitor Nilotinib is increasingly used to treat patients with chronic myeloid leukemia (CML). Although otherwise well-tolerated, Nilotinib has been associated with the occurrence of ...